This article is currently undergoing investigation.
Research Paper Volume 12, Issue 24 pp 25767—25777
Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells
Figure 4. The ROS levels in the ZnO-NPs, Cp, Gem, Cp+Gem, ZnO-NPs(Cp), ZnO-NPs(Gem) and ZnO NPs(Cp/Gem) groups are tested by CellROX probe method.